gg2
India finds Nestle baby food sample substandard
The gist
India's FSSAI found a Nestle follow-up formula sample substandard for biotin and filed three cases.
The action hits Nestle India's biggest revenue line and widens food-industry scrutiny.
How it unfolded
- Sep 18, 2026FSSAI said a sample of Nestle follow-up formula, a milk product for infants, was sub-standard with respect to biotin, also known as vitamin B7, and that it was pursuing legal action against the Swiss company.
- Sep 18, 2026FSSAI said a re-analysis of the sample found it non-conforming with prescribed biotin requirements under Indian laws, and that it had filed three separate adjudication cases against Nestle, including over NAN Excella Pro Stage 1 and Lactogen Pro 1 for misleading claims.
- Sep 18, 2026Shares in Nestle India fell almost 3% following news of the action, then recovered to close nearly flat.